This inventor holds 1 USPTO granted patent. Top assignee: Cor Therapeutics, Inc.. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001
Title: The Innovations of Lisa Nannizzi Alaimo
Introduction
Lisa Nannizzi Alaimo is a prominent inventor based in Los Altos, California. She has made significant contributions to the field of integrin-mediated signal transduction. Her work has implications for understanding biological processes and developing therapeutic agents.
Latest Patents
Lisa Nannizzi Alaimo holds a patent titled "Modulation of integrin-mediated signal transduction." This invention reveals that phosphorylation of cytoplasmic tyrosine residues in the β-subunit of integrins is essential for signal protein association. The patent outlines methods for identifying signaling partners involved in integrin-mediated signaling, as well as agents that can block this signaling pathway. These methods have the potential to modulate various biological and pathological processes.
Career Highlights
Lisa is associated with Cor Therapeutics, Inc., where she applies her expertise in integrin signaling. Her innovative work has positioned her as a key figure in her field, contributing to advancements in medical research and therapeutic development.
Collaborations
Some of her notable coworkers include David R. Phillips and Deborah Ann Law. Their collaborative efforts have further enhanced the research and development initiatives at Cor Therapeutics, Inc.
Conclusion
Lisa Nannizzi Alaimo's contributions to integrin-mediated signal transduction exemplify the impact of innovative thinking in the scientific community. Her work continues to influence research and therapeutic strategies in significant ways.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile